nodes	percent_of_prediction	percent_of_DWPC	metapath
Hydromorphone—CYP2D6—Hydroxyurea—head and neck cancer	0.244	0.458	CbGbCtD
Hydromorphone—CYP2C9—Fluorouracil—head and neck cancer	0.102	0.191	CbGbCtD
Hydromorphone—CYP2D6—Vinblastine—head and neck cancer	0.0864	0.162	CbGbCtD
Hydromorphone—CYP3A4—Vinblastine—head and neck cancer	0.0549	0.103	CbGbCtD
Hydromorphone—CYP3A4—Docetaxel—head and neck cancer	0.0453	0.085	CbGbCtD
Hydromorphone—Large intestine perforation—Docetaxel—head and neck cancer	0.0245	0.0668	CcSEcCtD
Hydromorphone—Unsteadiness—Fluorouracil—head and neck cancer	0.0141	0.0384	CcSEcCtD
Hydromorphone—Ileus paralytic—Vinblastine—head and neck cancer	0.00996	0.0272	CcSEcCtD
Hydromorphone—Application site pain—Fluorouracil—head and neck cancer	0.00643	0.0175	CcSEcCtD
Hydromorphone—Ileus—Vinblastine—head and neck cancer	0.00609	0.0166	CcSEcCtD
Hydromorphone—Nystagmus—Vinblastine—head and neck cancer	0.00603	0.0164	CcSEcCtD
Hydromorphone—Balance disorder—Fluorouracil—head and neck cancer	0.00517	0.0141	CcSEcCtD
Hydromorphone—Encephalopathy—Fluorouracil—head and neck cancer	0.00441	0.012	CcSEcCtD
Hydromorphone—Chest tightness—Docetaxel—head and neck cancer	0.00435	0.0119	CcSEcCtD
Hydromorphone—Hyperuricaemia—Hydroxyurea—head and neck cancer	0.00424	0.0115	CcSEcCtD
Hydromorphone—Hepatic enzyme increased—Hydroxyurea—head and neck cancer	0.00415	0.0113	CcSEcCtD
Hydromorphone—Blood uric acid increased—Hydroxyurea—head and neck cancer	0.004	0.0109	CcSEcCtD
Hydromorphone—Nystagmus—Fluorouracil—head and neck cancer	0.00396	0.0108	CcSEcCtD
Hydromorphone—Pulmonary oedema—Hydroxyurea—head and neck cancer	0.0035	0.00954	CcSEcCtD
Hydromorphone—Haemorrhoids—Docetaxel—head and neck cancer	0.00347	0.00947	CcSEcCtD
Hydromorphone—Disorientation—Hydroxyurea—head and neck cancer	0.00319	0.00869	CcSEcCtD
Hydromorphone—Intestinal obstruction—Docetaxel—head and neck cancer	0.00299	0.00817	CcSEcCtD
Hydromorphone—Dysarthria—Fluorouracil—head and neck cancer	0.00299	0.00815	CcSEcCtD
Hydromorphone—Ileus—Docetaxel—head and neck cancer	0.00288	0.00786	CcSEcCtD
Hydromorphone—Coma—Fluorouracil—head and neck cancer	0.00258	0.00705	CcSEcCtD
Hydromorphone—Breast disorder—Hydroxyurea—head and neck cancer	0.00258	0.00703	CcSEcCtD
Hydromorphone—Rhinorrhoea—Docetaxel—head and neck cancer	0.00252	0.00687	CcSEcCtD
Hydromorphone—Euphoric mood—Fluorouracil—head and neck cancer	0.00243	0.00663	CcSEcCtD
Hydromorphone—Depression—Vinblastine—head and neck cancer	0.0024	0.00655	CcSEcCtD
Hydromorphone—Swelling—Fluorouracil—head and neck cancer	0.00233	0.00635	CcSEcCtD
Hydromorphone—Chest discomfort—Docetaxel—head and neck cancer	0.00231	0.00629	CcSEcCtD
Hydromorphone—Dysuria—Hydroxyurea—head and neck cancer	0.00231	0.00629	CcSEcCtD
Hydromorphone—Disorientation—Fluorouracil—head and neck cancer	0.00229	0.00626	CcSEcCtD
Hydromorphone—Oliguria—Docetaxel—head and neck cancer	0.00222	0.00604	CcSEcCtD
Hydromorphone—Drug interaction—Docetaxel—head and neck cancer	0.0022	0.006	CcSEcCtD
Hydromorphone—Infestation NOS—Hydroxyurea—head and neck cancer	0.0022	0.00599	CcSEcCtD
Hydromorphone—Infestation—Hydroxyurea—head and neck cancer	0.0022	0.00599	CcSEcCtD
Hydromorphone—Drowsiness—Hydroxyurea—head and neck cancer	0.0022	0.00599	CcSEcCtD
Hydromorphone—Amnesia—Fluorouracil—head and neck cancer	0.00219	0.00596	CcSEcCtD
Hydromorphone—Hypoaesthesia—Vinblastine—head and neck cancer	0.00215	0.00587	CcSEcCtD
Hydromorphone—Stomatitis—Hydroxyurea—head and neck cancer	0.00214	0.00584	CcSEcCtD
Hydromorphone—Lethargy—Fluorouracil—head and neck cancer	0.0021	0.00571	CcSEcCtD
Hydromorphone—Hepatobiliary disease—Hydroxyurea—head and neck cancer	0.00208	0.00567	CcSEcCtD
Hydromorphone—Respiratory failure—Docetaxel—head and neck cancer	0.00208	0.00567	CcSEcCtD
Hydromorphone—Osteoarthritis—Fluorouracil—head and neck cancer	0.00205	0.0056	CcSEcCtD
Hydromorphone—Injection site reaction—Docetaxel—head and neck cancer	0.00203	0.00553	CcSEcCtD
Hydromorphone—Hallucination—Hydroxyurea—head and neck cancer	0.00196	0.00535	CcSEcCtD
Hydromorphone—Cardiac arrest—Fluorouracil—head and neck cancer	0.00195	0.00532	CcSEcCtD
Hydromorphone—Fluid retention—Docetaxel—head and neck cancer	0.00194	0.00528	CcSEcCtD
Hydromorphone—Nasopharyngitis—Fluorouracil—head and neck cancer	0.00184	0.00501	CcSEcCtD
Hydromorphone—Lightheadedness—Docetaxel—head and neck cancer	0.00183	0.00498	CcSEcCtD
Hydromorphone—Pulmonary oedema—Docetaxel—head and neck cancer	0.00182	0.00495	CcSEcCtD
Hydromorphone—Muscular weakness—Fluorouracil—head and neck cancer	0.00181	0.00494	CcSEcCtD
Hydromorphone—Angiopathy—Hydroxyurea—head and neck cancer	0.00179	0.00488	CcSEcCtD
Hydromorphone—Dysphagia—Fluorouracil—head and neck cancer	0.00177	0.00484	CcSEcCtD
Hydromorphone—Chills—Hydroxyurea—head and neck cancer	0.00177	0.00483	CcSEcCtD
Hydromorphone—Ill-defined disorder—Vinblastine—head and neck cancer	0.00175	0.00476	CcSEcCtD
Hydromorphone—Erythema—Hydroxyurea—head and neck cancer	0.00172	0.00468	CcSEcCtD
Hydromorphone—Malaise—Vinblastine—head and neck cancer	0.0017	0.00463	CcSEcCtD
Hydromorphone—Vertigo—Vinblastine—head and neck cancer	0.00169	0.00461	CcSEcCtD
Hydromorphone—Leukopenia—Vinblastine—head and neck cancer	0.00169	0.0046	CcSEcCtD
Hydromorphone—Swelling—Docetaxel—head and neck cancer	0.00168	0.00458	CcSEcCtD
Hydromorphone—Convulsion—Vinblastine—head and neck cancer	0.00163	0.00445	CcSEcCtD
Hydromorphone—Hypertension—Vinblastine—head and neck cancer	0.00163	0.00443	CcSEcCtD
Hydromorphone—Ill-defined disorder—Hydroxyurea—head and neck cancer	0.00159	0.00435	CcSEcCtD
Hydromorphone—Discomfort—Vinblastine—head and neck cancer	0.00158	0.00432	CcSEcCtD
Hydromorphone—Infestation NOS—Fluorouracil—head and neck cancer	0.00158	0.00431	CcSEcCtD
Hydromorphone—Infestation—Fluorouracil—head and neck cancer	0.00158	0.00431	CcSEcCtD
Hydromorphone—Visual disturbance—Docetaxel—head and neck cancer	0.00156	0.00426	CcSEcCtD
Hydromorphone—Malaise—Hydroxyurea—head and neck cancer	0.00155	0.00422	CcSEcCtD
Hydromorphone—Stomatitis—Fluorouracil—head and neck cancer	0.00154	0.0042	CcSEcCtD
Hydromorphone—Leukopenia—Hydroxyurea—head and neck cancer	0.00154	0.00419	CcSEcCtD
Hydromorphone—Lethargy—Docetaxel—head and neck cancer	0.00151	0.00412	CcSEcCtD
Hydromorphone—Convulsion—Hydroxyurea—head and neck cancer	0.00149	0.00406	CcSEcCtD
Hydromorphone—Hyponatraemia—Docetaxel—head and neck cancer	0.00149	0.00406	CcSEcCtD
Hydromorphone—Pain in extremity—Docetaxel—head and neck cancer	0.00148	0.00404	CcSEcCtD
Hydromorphone—Anorexia—Vinblastine—head and neck cancer	0.00147	0.004	CcSEcCtD
Hydromorphone—Migraine—Docetaxel—head and neck cancer	0.00146	0.00398	CcSEcCtD
Hydromorphone—Unspecified disorder of skin and subcutaneous tissue—Hydroxyurea—head and neck cancer	0.00145	0.00396	CcSEcCtD
Hydromorphone—Discomfort—Hydroxyurea—head and neck cancer	0.00144	0.00394	CcSEcCtD
Hydromorphone—Rhinitis—Fluorouracil—head and neck cancer	0.00142	0.00388	CcSEcCtD
Hydromorphone—Hypoaesthesia—Fluorouracil—head and neck cancer	0.00141	0.00385	CcSEcCtD
Hydromorphone—Infection—Hydroxyurea—head and neck cancer	0.00139	0.0038	CcSEcCtD
Hydromorphone—Paraesthesia—Vinblastine—head and neck cancer	0.00138	0.00376	CcSEcCtD
Hydromorphone—Dehydration—Docetaxel—head and neck cancer	0.00138	0.00376	CcSEcCtD
Hydromorphone—Nervous system disorder—Hydroxyurea—head and neck cancer	0.00137	0.00375	CcSEcCtD
Hydromorphone—Skin disorder—Hydroxyurea—head and neck cancer	0.00136	0.00371	CcSEcCtD
Hydromorphone—Orthostatic hypotension—Docetaxel—head and neck cancer	0.00135	0.00369	CcSEcCtD
Hydromorphone—Abdominal pain upper—Docetaxel—head and neck cancer	0.00135	0.00369	CcSEcCtD
Hydromorphone—Breast disorder—Docetaxel—head and neck cancer	0.00134	0.00365	CcSEcCtD
Hydromorphone—Anorexia—Hydroxyurea—head and neck cancer	0.00134	0.00364	CcSEcCtD
Hydromorphone—Decreased appetite—Vinblastine—head and neck cancer	0.00134	0.00364	CcSEcCtD
Hydromorphone—Cramp muscle—Docetaxel—head and neck cancer	0.00133	0.00364	CcSEcCtD
Hydromorphone—Aspartate aminotransferase increased—Docetaxel—head and neck cancer	0.00133	0.00364	CcSEcCtD
Hydromorphone—Nasopharyngitis—Docetaxel—head and neck cancer	0.00133	0.00361	CcSEcCtD
Hydromorphone—Constipation—Vinblastine—head and neck cancer	0.00131	0.00358	CcSEcCtD
Hydromorphone—Pain—Vinblastine—head and neck cancer	0.00131	0.00358	CcSEcCtD
Hydromorphone—Dysphagia—Docetaxel—head and neck cancer	0.00128	0.00349	CcSEcCtD
Hydromorphone—Arrhythmia—Fluorouracil—head and neck cancer	0.00127	0.00346	CcSEcCtD
Hydromorphone—Feeling abnormal—Vinblastine—head and neck cancer	0.00127	0.00345	CcSEcCtD
Hydromorphone—Bronchospasm—Docetaxel—head and neck cancer	0.00126	0.00343	CcSEcCtD
Hydromorphone—Gastrointestinal pain—Vinblastine—head and neck cancer	0.00126	0.00343	CcSEcCtD
Hydromorphone—Dyspnoea—Hydroxyurea—head and neck cancer	0.00125	0.00341	CcSEcCtD
Hydromorphone—Somnolence—Hydroxyurea—head and neck cancer	0.00125	0.0034	CcSEcCtD
Hydromorphone—Erythema—Fluorouracil—head and neck cancer	0.00124	0.00337	CcSEcCtD
Hydromorphone—Dyspepsia—Hydroxyurea—head and neck cancer	0.00123	0.00336	CcSEcCtD
Hydromorphone—Decreased appetite—Hydroxyurea—head and neck cancer	0.00122	0.00332	CcSEcCtD
Hydromorphone—Abdominal pain—Vinblastine—head and neck cancer	0.00122	0.00331	CcSEcCtD
Hydromorphone—Gastrointestinal disorder—Hydroxyurea—head and neck cancer	0.00121	0.0033	CcSEcCtD
Hydromorphone—Fatigue—Hydroxyurea—head and neck cancer	0.00121	0.0033	CcSEcCtD
Hydromorphone—Constipation—Hydroxyurea—head and neck cancer	0.0012	0.00327	CcSEcCtD
Hydromorphone—Pain—Hydroxyurea—head and neck cancer	0.0012	0.00327	CcSEcCtD
Hydromorphone—Vision blurred—Fluorouracil—head and neck cancer	0.00117	0.00318	CcSEcCtD
Hydromorphone—Weight decreased—Docetaxel—head and neck cancer	0.00116	0.00316	CcSEcCtD
Hydromorphone—Feeling abnormal—Hydroxyurea—head and neck cancer	0.00116	0.00315	CcSEcCtD
Hydromorphone—Infestation NOS—Docetaxel—head and neck cancer	0.00114	0.00311	CcSEcCtD
Hydromorphone—Infestation—Docetaxel—head and neck cancer	0.00114	0.00311	CcSEcCtD
Hydromorphone—Hypersensitivity—Vinblastine—head and neck cancer	0.00113	0.00309	CcSEcCtD
Hydromorphone—Stomatitis—Docetaxel—head and neck cancer	0.00111	0.00303	CcSEcCtD
Hydromorphone—Body temperature increased—Hydroxyurea—head and neck cancer	0.00111	0.00302	CcSEcCtD
Hydromorphone—Leukopenia—Fluorouracil—head and neck cancer	0.00111	0.00302	CcSEcCtD
Hydromorphone—Asthenia—Vinblastine—head and neck cancer	0.0011	0.00301	CcSEcCtD
Hydromorphone—Hepatobiliary disease—Docetaxel—head and neck cancer	0.00108	0.00294	CcSEcCtD
Hydromorphone—Convulsion—Fluorouracil—head and neck cancer	0.00107	0.00292	CcSEcCtD
Hydromorphone—Chest pain—Fluorouracil—head and neck cancer	0.00105	0.00287	CcSEcCtD
Hydromorphone—Myalgia—Fluorouracil—head and neck cancer	0.00105	0.00287	CcSEcCtD
Hydromorphone—Diarrhoea—Vinblastine—head and neck cancer	0.00105	0.00287	CcSEcCtD
Hydromorphone—Discomfort—Fluorouracil—head and neck cancer	0.00104	0.00284	CcSEcCtD
Hydromorphone—Hypersensitivity—Hydroxyurea—head and neck cancer	0.00103	0.00282	CcSEcCtD
Hydromorphone—Rhinitis—Docetaxel—head and neck cancer	0.00103	0.0028	CcSEcCtD
Hydromorphone—Hypoaesthesia—Docetaxel—head and neck cancer	0.00102	0.00278	CcSEcCtD
Hydromorphone—Confusional state—Fluorouracil—head and neck cancer	0.00102	0.00277	CcSEcCtD
Hydromorphone—Dizziness—Vinblastine—head and neck cancer	0.00102	0.00277	CcSEcCtD
Hydromorphone—Urinary tract disorder—Docetaxel—head and neck cancer	0.00101	0.00276	CcSEcCtD
Hydromorphone—Oedema peripheral—Docetaxel—head and neck cancer	0.00101	0.00275	CcSEcCtD
Hydromorphone—Anaphylactic shock—Fluorouracil—head and neck cancer	0.00101	0.00275	CcSEcCtD
Hydromorphone—Connective tissue disorder—Docetaxel—head and neck cancer	0.00101	0.00275	CcSEcCtD
Hydromorphone—Asthenia—Hydroxyurea—head and neck cancer	0.00101	0.00274	CcSEcCtD
Hydromorphone—Urethral disorder—Docetaxel—head and neck cancer	0.001	0.00274	CcSEcCtD
Hydromorphone—Infection—Fluorouracil—head and neck cancer	0.001	0.00273	CcSEcCtD
Hydromorphone—Nervous system disorder—Fluorouracil—head and neck cancer	0.00099	0.0027	CcSEcCtD
Hydromorphone—Visual impairment—Docetaxel—head and neck cancer	0.000988	0.00269	CcSEcCtD
Hydromorphone—Tachycardia—Fluorouracil—head and neck cancer	0.000985	0.00269	CcSEcCtD
Hydromorphone—Vomiting—Vinblastine—head and neck cancer	0.000977	0.00266	CcSEcCtD
Hydromorphone—Headache—Vinblastine—head and neck cancer	0.000963	0.00263	CcSEcCtD
Hydromorphone—Anorexia—Fluorouracil—head and neck cancer	0.000962	0.00262	CcSEcCtD
Hydromorphone—Diarrhoea—Hydroxyurea—head and neck cancer	0.000959	0.00262	CcSEcCtD
Hydromorphone—Eye disorder—Docetaxel—head and neck cancer	0.000958	0.00261	CcSEcCtD
Hydromorphone—Flushing—Docetaxel—head and neck cancer	0.000951	0.00259	CcSEcCtD
Hydromorphone—Cardiac disorder—Docetaxel—head and neck cancer	0.000951	0.00259	CcSEcCtD
Hydromorphone—Hypotension—Fluorouracil—head and neck cancer	0.000943	0.00257	CcSEcCtD
Hydromorphone—Angiopathy—Docetaxel—head and neck cancer	0.00093	0.00254	CcSEcCtD
Hydromorphone—Dizziness—Hydroxyurea—head and neck cancer	0.000927	0.00253	CcSEcCtD
Hydromorphone—Immune system disorder—Docetaxel—head and neck cancer	0.000926	0.00252	CcSEcCtD
Hydromorphone—Mediastinal disorder—Docetaxel—head and neck cancer	0.000924	0.00252	CcSEcCtD
Hydromorphone—Chills—Docetaxel—head and neck cancer	0.00092	0.00251	CcSEcCtD
Hydromorphone—Musculoskeletal discomfort—Fluorouracil—head and neck cancer	0.000919	0.00251	CcSEcCtD
Hydromorphone—Arrhythmia—Docetaxel—head and neck cancer	0.000916	0.0025	CcSEcCtD
Hydromorphone—Nausea—Vinblastine—head and neck cancer	0.000913	0.00249	CcSEcCtD
Hydromorphone—Insomnia—Fluorouracil—head and neck cancer	0.000913	0.00249	CcSEcCtD
Hydromorphone—Paraesthesia—Fluorouracil—head and neck cancer	0.000906	0.00247	CcSEcCtD
Hydromorphone—Dyspnoea—Fluorouracil—head and neck cancer	0.0009	0.00245	CcSEcCtD
Hydromorphone—Mental disorder—Docetaxel—head and neck cancer	0.000898	0.00245	CcSEcCtD
Hydromorphone—Somnolence—Fluorouracil—head and neck cancer	0.000897	0.00245	CcSEcCtD
Hydromorphone—Erythema—Docetaxel—head and neck cancer	0.000892	0.00243	CcSEcCtD
Hydromorphone—Malnutrition—Docetaxel—head and neck cancer	0.000892	0.00243	CcSEcCtD
Hydromorphone—Vomiting—Hydroxyurea—head and neck cancer	0.000891	0.00243	CcSEcCtD
Hydromorphone—Dyspepsia—Fluorouracil—head and neck cancer	0.000888	0.00242	CcSEcCtD
Hydromorphone—Rash—Hydroxyurea—head and neck cancer	0.000884	0.00241	CcSEcCtD
Hydromorphone—Dermatitis—Hydroxyurea—head and neck cancer	0.000883	0.00241	CcSEcCtD
Hydromorphone—Headache—Hydroxyurea—head and neck cancer	0.000878	0.00239	CcSEcCtD
Hydromorphone—Decreased appetite—Fluorouracil—head and neck cancer	0.000877	0.00239	CcSEcCtD
Hydromorphone—Dysgeusia—Docetaxel—head and neck cancer	0.000874	0.00238	CcSEcCtD
Hydromorphone—Gastrointestinal disorder—Fluorouracil—head and neck cancer	0.000871	0.00238	CcSEcCtD
Hydromorphone—Back pain—Docetaxel—head and neck cancer	0.000863	0.00235	CcSEcCtD
Hydromorphone—Pain—Fluorouracil—head and neck cancer	0.000863	0.00235	CcSEcCtD
Hydromorphone—Muscle spasms—Docetaxel—head and neck cancer	0.000858	0.00234	CcSEcCtD
Hydromorphone—Nausea—Hydroxyurea—head and neck cancer	0.000833	0.00227	CcSEcCtD
Hydromorphone—Feeling abnormal—Fluorouracil—head and neck cancer	0.000832	0.00227	CcSEcCtD
Hydromorphone—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—RARB—head and neck cancer	0.000823	0.00817	CbGpPWpGaD
Hydromorphone—OPRM1—IL4-mediated signaling events—BCL2L1—head and neck cancer	0.000804	0.00799	CbGpPWpGaD
Hydromorphone—Urticaria—Fluorouracil—head and neck cancer	0.000802	0.00219	CcSEcCtD
Hydromorphone—Syncope—Docetaxel—head and neck cancer	0.0008	0.00218	CcSEcCtD
Hydromorphone—Leukopenia—Docetaxel—head and neck cancer	0.000799	0.00218	CcSEcCtD
Hydromorphone—PTGS1—Prostaglandin Synthesis and Regulation—PTGS2—head and neck cancer	0.000798	0.00793	CbGpPWpGaD
Hydromorphone—Body temperature increased—Fluorouracil—head and neck cancer	0.000798	0.00217	CcSEcCtD
Hydromorphone—Palpitations—Docetaxel—head and neck cancer	0.000789	0.00215	CcSEcCtD
Hydromorphone—Loss of consciousness—Docetaxel—head and neck cancer	0.000784	0.00214	CcSEcCtD
Hydromorphone—Cough—Docetaxel—head and neck cancer	0.000779	0.00212	CcSEcCtD
Hydromorphone—Convulsion—Docetaxel—head and neck cancer	0.000773	0.00211	CcSEcCtD
Hydromorphone—Hypertension—Docetaxel—head and neck cancer	0.00077	0.0021	CcSEcCtD
Hydromorphone—CYP3A4—Fatty Acid Omega Oxidation—CYP1A1—head and neck cancer	0.00077	0.00765	CbGpPWpGaD
Hydromorphone—OPRM1—Peptide ligand-binding receptors—GRP—head and neck cancer	0.000761	0.00756	CbGpPWpGaD
Hydromorphone—Arthralgia—Docetaxel—head and neck cancer	0.00076	0.00207	CcSEcCtD
Hydromorphone—Myalgia—Docetaxel—head and neck cancer	0.00076	0.00207	CcSEcCtD
Hydromorphone—Chest pain—Docetaxel—head and neck cancer	0.00076	0.00207	CcSEcCtD
Hydromorphone—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—head and neck cancer	0.000754	0.00206	CcSEcCtD
Hydromorphone—Hypersensitivity—Fluorouracil—head and neck cancer	0.000743	0.00203	CcSEcCtD
Hydromorphone—Dry mouth—Docetaxel—head and neck cancer	0.000743	0.00203	CcSEcCtD
Hydromorphone—CYP3A4—Estrogen metabolism—GSTM1—head and neck cancer	0.000739	0.00734	CbGpPWpGaD
Hydromorphone—UGT1A9—Phase II conjugation—GSTM1—head and neck cancer	0.000735	0.0073	CbGpPWpGaD
Hydromorphone—Confusional state—Docetaxel—head and neck cancer	0.000734	0.002	CcSEcCtD
Hydromorphone—OPRK1—Class A/1 (Rhodopsin-like receptors)—KISS1—head and neck cancer	0.000733	0.00729	CbGpPWpGaD
Hydromorphone—CYP2D6—Melatonin metabolism and effects—CYP1A1—head and neck cancer	0.000732	0.00727	CbGpPWpGaD
Hydromorphone—Anaphylactic shock—Docetaxel—head and neck cancer	0.000728	0.00199	CcSEcCtD
Hydromorphone—Infection—Docetaxel—head and neck cancer	0.000724	0.00197	CcSEcCtD
Hydromorphone—Shock—Docetaxel—head and neck cancer	0.000717	0.00195	CcSEcCtD
Hydromorphone—Nervous system disorder—Docetaxel—head and neck cancer	0.000714	0.00195	CcSEcCtD
Hydromorphone—Pruritus—Fluorouracil—head and neck cancer	0.000714	0.00195	CcSEcCtD
Hydromorphone—Tachycardia—Docetaxel—head and neck cancer	0.000711	0.00194	CcSEcCtD
Hydromorphone—PTGS1—Biological oxidations—NAT2—head and neck cancer	0.000709	0.00705	CbGpPWpGaD
Hydromorphone—Skin disorder—Docetaxel—head and neck cancer	0.000707	0.00193	CcSEcCtD
Hydromorphone—CYP3A4—Estrogen metabolism—CYP1A1—head and neck cancer	0.000701	0.00696	CbGpPWpGaD
Hydromorphone—UGT1A9—Fatty acid, triacylglycerol, and ketone body metabolism—YAP1—head and neck cancer	0.000698	0.00694	CbGpPWpGaD
Hydromorphone—Anorexia—Docetaxel—head and neck cancer	0.000694	0.00189	CcSEcCtD
Hydromorphone—Diarrhoea—Fluorouracil—head and neck cancer	0.00069	0.00188	CcSEcCtD
Hydromorphone—OPRD1—Class A/1 (Rhodopsin-like receptors)—GRP—head and neck cancer	0.000689	0.00684	CbGpPWpGaD
Hydromorphone—Hypotension—Docetaxel—head and neck cancer	0.000681	0.00186	CcSEcCtD
Hydromorphone—Dizziness—Fluorouracil—head and neck cancer	0.000667	0.00182	CcSEcCtD
Hydromorphone—Musculoskeletal discomfort—Docetaxel—head and neck cancer	0.000664	0.00181	CcSEcCtD
Hydromorphone—Insomnia—Docetaxel—head and neck cancer	0.000659	0.0018	CcSEcCtD
Hydromorphone—Paraesthesia—Docetaxel—head and neck cancer	0.000654	0.00178	CcSEcCtD
Hydromorphone—Dyspnoea—Docetaxel—head and neck cancer	0.000649	0.00177	CcSEcCtD
Hydromorphone—Somnolence—Docetaxel—head and neck cancer	0.000647	0.00177	CcSEcCtD
Hydromorphone—UGT1A9—Aryl Hydrocarbon Receptor Pathway—IL2—head and neck cancer	0.000645	0.00641	CbGpPWpGaD
Hydromorphone—CYP3A4—Xenobiotics—CYP1A1—head and neck cancer	0.000644	0.0064	CbGpPWpGaD
Hydromorphone—Vomiting—Fluorouracil—head and neck cancer	0.000642	0.00175	CcSEcCtD
Hydromorphone—Dyspepsia—Docetaxel—head and neck cancer	0.000641	0.00175	CcSEcCtD
Hydromorphone—OPRD1—GPCR ligand binding—KISS1—head and neck cancer	0.000637	0.00633	CbGpPWpGaD
Hydromorphone—Rash—Fluorouracil—head and neck cancer	0.000636	0.00173	CcSEcCtD
Hydromorphone—Dermatitis—Fluorouracil—head and neck cancer	0.000636	0.00173	CcSEcCtD
Hydromorphone—Decreased appetite—Docetaxel—head and neck cancer	0.000633	0.00173	CcSEcCtD
Hydromorphone—Headache—Fluorouracil—head and neck cancer	0.000632	0.00172	CcSEcCtD
Hydromorphone—Gastrointestinal disorder—Docetaxel—head and neck cancer	0.000629	0.00171	CcSEcCtD
Hydromorphone—Fatigue—Docetaxel—head and neck cancer	0.000628	0.00171	CcSEcCtD
Hydromorphone—PTGS1—Phase 1 - Functionalization of compounds—CYP1A1—head and neck cancer	0.000625	0.00621	CbGpPWpGaD
Hydromorphone—Pain—Docetaxel—head and neck cancer	0.000623	0.0017	CcSEcCtD
Hydromorphone—Constipation—Docetaxel—head and neck cancer	0.000623	0.0017	CcSEcCtD
Hydromorphone—OPRM1—Class A/1 (Rhodopsin-like receptors)—KISS1—head and neck cancer	0.00062	0.00616	CbGpPWpGaD
Hydromorphone—CYP3A4—Tamoxifen metabolism—CYP1A1—head and neck cancer	0.000619	0.00615	CbGpPWpGaD
Hydromorphone—OPRK1—Class A/1 (Rhodopsin-like receptors)—GRP—head and neck cancer	0.000604	0.006	CbGpPWpGaD
Hydromorphone—PTGS1—Selenium Micronutrient Network—SOD2—head and neck cancer	0.000601	0.00597	CbGpPWpGaD
Hydromorphone—Feeling abnormal—Docetaxel—head and neck cancer	0.0006	0.00164	CcSEcCtD
Hydromorphone—Nausea—Fluorouracil—head and neck cancer	0.000599	0.00163	CcSEcCtD
Hydromorphone—Gastrointestinal pain—Docetaxel—head and neck cancer	0.000596	0.00162	CcSEcCtD
Hydromorphone—UGT1A9—PPARA activates gene expression—CYP1A1—head and neck cancer	0.000583	0.00579	CbGpPWpGaD
Hydromorphone—Abdominal pain—Docetaxel—head and neck cancer	0.000576	0.00157	CcSEcCtD
Hydromorphone—Body temperature increased—Docetaxel—head and neck cancer	0.000576	0.00157	CcSEcCtD
Hydromorphone—PTGS1—Selenium Micronutrient Network—GPX1—head and neck cancer	0.000573	0.0057	CbGpPWpGaD
Hydromorphone—UGT1A9—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—CYP1A1—head and neck cancer	0.00057	0.00566	CbGpPWpGaD
Hydromorphone—OPRK1—GPCR ligand binding—KISS1—head and neck cancer	0.000558	0.00555	CbGpPWpGaD
Hydromorphone—Hypersensitivity—Docetaxel—head and neck cancer	0.000537	0.00146	CcSEcCtD
Hydromorphone—PTGS1—Arachidonic acid metabolism—PTGS2—head and neck cancer	0.000531	0.00527	CbGpPWpGaD
Hydromorphone—OPRD1—GPCR ligand binding—GRP—head and neck cancer	0.000524	0.00521	CbGpPWpGaD
Hydromorphone—Asthenia—Docetaxel—head and neck cancer	0.000523	0.00142	CcSEcCtD
Hydromorphone—Pruritus—Docetaxel—head and neck cancer	0.000515	0.0014	CcSEcCtD
Hydromorphone—OPRM1—Class A/1 (Rhodopsin-like receptors)—GRP—head and neck cancer	0.00051	0.00507	CbGpPWpGaD
Hydromorphone—Diarrhoea—Docetaxel—head and neck cancer	0.000498	0.00136	CcSEcCtD
Hydromorphone—UGT1A9—Aryl Hydrocarbon Receptor Pathway—EGFR—head and neck cancer	0.000493	0.0049	CbGpPWpGaD
Hydromorphone—UGT1A9—NRF2 pathway—GSTM1—head and neck cancer	0.00049	0.00487	CbGpPWpGaD
Hydromorphone—Dizziness—Docetaxel—head and neck cancer	0.000482	0.00131	CcSEcCtD
Hydromorphone—CYP2C9—Arachidonic acid metabolism—GPX1—head and neck cancer	0.000474	0.00471	CbGpPWpGaD
Hydromorphone—OPRM1—GPCR ligand binding—KISS1—head and neck cancer	0.000472	0.00469	CbGpPWpGaD
Hydromorphone—CYP2C9—Arachidonic acid metabolism—CYP1A1—head and neck cancer	0.000469	0.00466	CbGpPWpGaD
Hydromorphone—Vomiting—Docetaxel—head and neck cancer	0.000463	0.00126	CcSEcCtD
Hydromorphone—OPRK1—GPCR ligand binding—GRP—head and neck cancer	0.00046	0.00457	CbGpPWpGaD
Hydromorphone—Rash—Docetaxel—head and neck cancer	0.000459	0.00125	CcSEcCtD
Hydromorphone—Dermatitis—Docetaxel—head and neck cancer	0.000459	0.00125	CcSEcCtD
Hydromorphone—Headache—Docetaxel—head and neck cancer	0.000456	0.00124	CcSEcCtD
Hydromorphone—Nausea—Docetaxel—head and neck cancer	0.000433	0.00118	CcSEcCtD
Hydromorphone—UGT1A9—Biological oxidations—GSTM1—head and neck cancer	0.00043	0.00427	CbGpPWpGaD
Hydromorphone—UGT1A9—Metapathway biotransformation—GSTM1—head and neck cancer	0.000424	0.00421	CbGpPWpGaD
Hydromorphone—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP1A1—head and neck cancer	0.000409	0.00406	CbGpPWpGaD
Hydromorphone—UGT1A9—Biological oxidations—CYP1A1—head and neck cancer	0.000407	0.00405	CbGpPWpGaD
Hydromorphone—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP1A1—head and neck cancer	0.000405	0.00403	CbGpPWpGaD
Hydromorphone—CYP2D6—Oxidation by Cytochrome P450—CYP1A1—head and neck cancer	0.000404	0.00401	CbGpPWpGaD
Hydromorphone—UGT1A9—Metapathway biotransformation—CYP1A1—head and neck cancer	0.000402	0.00399	CbGpPWpGaD
Hydromorphone—CYP2C9—Oxidation by Cytochrome P450—CYP1A1—head and neck cancer	0.0004	0.00397	CbGpPWpGaD
Hydromorphone—UGT1A9—Fatty acid, triacylglycerol, and ketone body metabolism—CYP1A1—head and neck cancer	0.000393	0.0039	CbGpPWpGaD
Hydromorphone—OPRM1—GPCR ligand binding—GRP—head and neck cancer	0.000389	0.00386	CbGpPWpGaD
Hydromorphone—CYP2D6—Biological oxidations—NAT2—head and neck cancer	0.000376	0.00374	CbGpPWpGaD
Hydromorphone—CYP2C9—Biological oxidations—NAT2—head and neck cancer	0.000373	0.0037	CbGpPWpGaD
Hydromorphone—CYP2D6—Metapathway biotransformation—NAT2—head and neck cancer	0.000371	0.00369	CbGpPWpGaD
Hydromorphone—CYP2C9—Metapathway biotransformation—NAT2—head and neck cancer	0.000368	0.00365	CbGpPWpGaD
Hydromorphone—OPRD1—GPCR downstream signaling—KISS1—head and neck cancer	0.00036	0.00358	CbGpPWpGaD
Hydromorphone—UGT1A9—Metabolism—UROD—head and neck cancer	0.000358	0.00356	CbGpPWpGaD
Hydromorphone—PTGS1—Biological oxidations—GSTM1—head and neck cancer	0.00035	0.00348	CbGpPWpGaD
Hydromorphone—PTGS1—Selenium Micronutrient Network—PTGS2—head and neck cancer	0.000338	0.00335	CbGpPWpGaD
Hydromorphone—PTGS1—Biological oxidations—CYP1A1—head and neck cancer	0.000332	0.0033	CbGpPWpGaD
Hydromorphone—CYP2D6—Phase 1 - Functionalization of compounds—CYP1A1—head and neck cancer	0.000332	0.00329	CbGpPWpGaD
Hydromorphone—CYP3A4—Tryptophan metabolism—CYP1A1—head and neck cancer	0.000331	0.00329	CbGpPWpGaD
Hydromorphone—OPRM1—IL4-mediated signaling events—PIK3CA—head and neck cancer	0.00033	0.00328	CbGpPWpGaD
Hydromorphone—CYP2C9—Phase 1 - Functionalization of compounds—CYP1A1—head and neck cancer	0.000329	0.00326	CbGpPWpGaD
Hydromorphone—OPRD1—Signaling by GPCR—KISS1—head and neck cancer	0.000327	0.00325	CbGpPWpGaD
Hydromorphone—OPRK1—GPCR downstream signaling—KISS1—head and neck cancer	0.000316	0.00314	CbGpPWpGaD
Hydromorphone—OPRM1—Opioid Signalling—MAPK1—head and neck cancer	0.000307	0.00305	CbGpPWpGaD
Hydromorphone—OPRD1—GPCR downstream signaling—GRP—head and neck cancer	0.000296	0.00294	CbGpPWpGaD
Hydromorphone—OPRM1—TCR Signaling Pathway—MAPK3—head and neck cancer	0.000296	0.00294	CbGpPWpGaD
Hydromorphone—PTGS1—Metabolism—UROD—head and neck cancer	0.000292	0.0029	CbGpPWpGaD
Hydromorphone—OPRK1—Signaling by GPCR—KISS1—head and neck cancer	0.000287	0.00285	CbGpPWpGaD
Hydromorphone—OPRM1—TCR Signaling Pathway—MAPK1—head and neck cancer	0.000282	0.0028	CbGpPWpGaD
Hydromorphone—CYP2C9—Arachidonic acid metabolism—PTGS2—head and neck cancer	0.000279	0.00277	CbGpPWpGaD
Hydromorphone—UGT1A9—Metabolism of lipids and lipoproteins—YAP1—head and neck cancer	0.000278	0.00276	CbGpPWpGaD
Hydromorphone—OPRM1—IL4-mediated signaling events—AKT1—head and neck cancer	0.000269	0.00268	CbGpPWpGaD
Hydromorphone—OPRD1—Signaling by GPCR—GRP—head and neck cancer	0.000269	0.00267	CbGpPWpGaD
Hydromorphone—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A1—head and neck cancer	0.000267	0.00266	CbGpPWpGaD
Hydromorphone—OPRM1—GPCR downstream signaling—KISS1—head and neck cancer	0.000267	0.00265	CbGpPWpGaD
Hydromorphone—CYP3A4—Oxidation by Cytochrome P450—CYP1A1—head and neck cancer	0.000264	0.00262	CbGpPWpGaD
Hydromorphone—OPRK1—GPCR downstream signaling—GRP—head and neck cancer	0.00026	0.00258	CbGpPWpGaD
Hydromorphone—CYP3A4—Biological oxidations—NAT2—head and neck cancer	0.000246	0.00244	CbGpPWpGaD
Hydromorphone—CYP3A4—Metapathway biotransformation—NAT2—head and neck cancer	0.000243	0.00241	CbGpPWpGaD
Hydromorphone—OPRM1—Signaling by GPCR—KISS1—head and neck cancer	0.000242	0.00241	CbGpPWpGaD
Hydromorphone—OPRK1—Signaling by GPCR—GRP—head and neck cancer	0.000236	0.00234	CbGpPWpGaD
Hydromorphone—PTGS1—Metabolism of lipids and lipoproteins—YAP1—head and neck cancer	0.000227	0.00225	CbGpPWpGaD
Hydromorphone—OPRM1—TCR Signaling Pathway—HRAS—head and neck cancer	0.000226	0.00225	CbGpPWpGaD
Hydromorphone—OPRM1—GPCR downstream signaling—GRP—head and neck cancer	0.00022	0.00218	CbGpPWpGaD
Hydromorphone—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A1—head and neck cancer	0.000217	0.00215	CbGpPWpGaD
Hydromorphone—OPRM1—TCR Signaling Pathway—AKT1—head and neck cancer	0.0002	0.00199	CbGpPWpGaD
Hydromorphone—OPRM1—Signaling by GPCR—GRP—head and neck cancer	0.000199	0.00198	CbGpPWpGaD
Hydromorphone—OPRD1—Signaling Pathways—KISS1—head and neck cancer	0.000193	0.00192	CbGpPWpGaD
Hydromorphone—CYP2D6—Biological oxidations—GSTM1—head and neck cancer	0.000186	0.00185	CbGpPWpGaD
Hydromorphone—CYP2C9—Biological oxidations—GSTM1—head and neck cancer	0.000184	0.00183	CbGpPWpGaD
Hydromorphone—CYP2D6—Metapathway biotransformation—GSTM1—head and neck cancer	0.000183	0.00182	CbGpPWpGaD
Hydromorphone—CYP2C9—Metapathway biotransformation—GSTM1—head and neck cancer	0.000182	0.0018	CbGpPWpGaD
Hydromorphone—CYP2D6—Biological oxidations—CYP1A1—head and neck cancer	0.000176	0.00175	CbGpPWpGaD
Hydromorphone—CYP2C9—Biological oxidations—CYP1A1—head and neck cancer	0.000175	0.00173	CbGpPWpGaD
Hydromorphone—CYP2D6—Metapathway biotransformation—CYP1A1—head and neck cancer	0.000174	0.00173	CbGpPWpGaD
Hydromorphone—CYP2C9—Metapathway biotransformation—CYP1A1—head and neck cancer	0.000172	0.00171	CbGpPWpGaD
Hydromorphone—OPRK1—Signaling Pathways—KISS1—head and neck cancer	0.000169	0.00168	CbGpPWpGaD
Hydromorphone—OPRD1—Signaling Pathways—GRP—head and neck cancer	0.000159	0.00158	CbGpPWpGaD
Hydromorphone—UGT1A9—Metabolism of lipids and lipoproteins—GPX1—head and neck cancer	0.000158	0.00157	CbGpPWpGaD
Hydromorphone—UGT1A9—Metabolism of lipids and lipoproteins—CYP1A1—head and neck cancer	0.000156	0.00155	CbGpPWpGaD
Hydromorphone—CYP2D6—Metabolism—UROD—head and neck cancer	0.000155	0.00154	CbGpPWpGaD
Hydromorphone—OPRD1—Signaling Pathways—STAT6—head and neck cancer	0.000154	0.00153	CbGpPWpGaD
Hydromorphone—CYP2C9—Metabolism—UROD—head and neck cancer	0.000154	0.00153	CbGpPWpGaD
Hydromorphone—UGT1A9—Metabolism—NAT2—head and neck cancer	0.000149	0.00148	CbGpPWpGaD
Hydromorphone—OPRM1—Signaling Pathways—KISS1—head and neck cancer	0.000143	0.00142	CbGpPWpGaD
Hydromorphone—OPRK1—Signaling Pathways—GRP—head and neck cancer	0.000139	0.00139	CbGpPWpGaD
Hydromorphone—OPRD1—Signaling Pathways—YAP1—head and neck cancer	0.000137	0.00136	CbGpPWpGaD
Hydromorphone—OPRK1—Signaling Pathways—STAT6—head and neck cancer	0.000135	0.00134	CbGpPWpGaD
Hydromorphone—UGT1A9—Metabolism—DPYD—head and neck cancer	0.00013	0.0013	CbGpPWpGaD
Hydromorphone—PTGS1—Metabolism of lipids and lipoproteins—GPX1—head and neck cancer	0.000129	0.00128	CbGpPWpGaD
Hydromorphone—PTGS1—Metabolism of lipids and lipoproteins—CYP1A1—head and neck cancer	0.000128	0.00127	CbGpPWpGaD
Hydromorphone—UGT1A9—Metabolism—YAP1—head and neck cancer	0.000124	0.00123	CbGpPWpGaD
Hydromorphone—CYP3A4—Biological oxidations—GSTM1—head and neck cancer	0.000121	0.00121	CbGpPWpGaD
Hydromorphone—PTGS1—Metabolism—NAT2—head and neck cancer	0.000121	0.0012	CbGpPWpGaD
Hydromorphone—CYP3A4—Metapathway biotransformation—GSTM1—head and neck cancer	0.00012	0.00119	CbGpPWpGaD
Hydromorphone—OPRK1—Signaling Pathways—YAP1—head and neck cancer	0.00012	0.00119	CbGpPWpGaD
Hydromorphone—CYP2C9—Metabolism of lipids and lipoproteins—YAP1—head and neck cancer	0.000119	0.00118	CbGpPWpGaD
Hydromorphone—OPRM1—Signaling Pathways—GRP—head and neck cancer	0.000118	0.00117	CbGpPWpGaD
Hydromorphone—CYP3A4—Biological oxidations—CYP1A1—head and neck cancer	0.000115	0.00114	CbGpPWpGaD
Hydromorphone—OPRM1—Signaling Pathways—STAT6—head and neck cancer	0.000114	0.00114	CbGpPWpGaD
Hydromorphone—CYP3A4—Metapathway biotransformation—CYP1A1—head and neck cancer	0.000114	0.00113	CbGpPWpGaD
Hydromorphone—PTGS1—Metabolism—DPYD—head and neck cancer	0.000106	0.00106	CbGpPWpGaD
Hydromorphone—CYP3A4—Metabolism—UROD—head and neck cancer	0.000101	0.00101	CbGpPWpGaD
Hydromorphone—OPRM1—Signaling Pathways—YAP1—head and neck cancer	0.000101	0.00101	CbGpPWpGaD
Hydromorphone—PTGS1—Metabolism—YAP1—head and neck cancer	0.000101	0.001	CbGpPWpGaD
Hydromorphone—UGT1A9—Metabolism of lipids and lipoproteins—PTGS2—head and neck cancer	9.3e-05	0.000924	CbGpPWpGaD
Hydromorphone—UGT1A9—Metabolism of lipids and lipoproteins—PTEN—head and neck cancer	8.11e-05	0.000806	CbGpPWpGaD
Hydromorphone—OPRD1—GPCR downstream signaling—IL2—head and neck cancer	7.9e-05	0.000785	CbGpPWpGaD
Hydromorphone—PTGS1—Metabolism of lipids and lipoproteins—PTGS2—head and neck cancer	7.58e-05	0.000753	CbGpPWpGaD
Hydromorphone—UGT1A9—Metabolism—TYMS—head and neck cancer	7.43e-05	0.000739	CbGpPWpGaD
Hydromorphone—UGT1A9—Metabolism—GSTM1—head and neck cancer	7.35e-05	0.00073	CbGpPWpGaD
Hydromorphone—OPRD1—Signaling by GPCR—IL2—head and neck cancer	7.17e-05	0.000712	CbGpPWpGaD
Hydromorphone—UGT1A9—Metabolism—GPX1—head and neck cancer	7.04e-05	0.000699	CbGpPWpGaD
Hydromorphone—UGT1A9—Metabolism—CYP1A1—head and neck cancer	6.97e-05	0.000692	CbGpPWpGaD
Hydromorphone—OPRK1—GPCR downstream signaling—IL2—head and neck cancer	6.93e-05	0.000688	CbGpPWpGaD
Hydromorphone—CYP2C9—Metabolism of lipids and lipoproteins—GPX1—head and neck cancer	6.77e-05	0.000673	CbGpPWpGaD
Hydromorphone—CYP2C9—Metabolism of lipids and lipoproteins—CYP1A1—head and neck cancer	6.7e-05	0.000666	CbGpPWpGaD
Hydromorphone—PTGS1—Metabolism of lipids and lipoproteins—PTEN—head and neck cancer	6.61e-05	0.000657	CbGpPWpGaD
Hydromorphone—CYP2D6—Metabolism—NAT2—head and neck cancer	6.43e-05	0.000639	CbGpPWpGaD
Hydromorphone—CYP2C9—Metabolism—NAT2—head and neck cancer	6.38e-05	0.000633	CbGpPWpGaD
Hydromorphone—OPRK1—Signaling by GPCR—IL2—head and neck cancer	6.29e-05	0.000625	CbGpPWpGaD
Hydromorphone—OPRD1—Signaling Pathways—NOTCH1—head and neck cancer	6.16e-05	0.000612	CbGpPWpGaD
Hydromorphone—PTGS1—Metabolism—TYMS—head and neck cancer	6.06e-05	0.000602	CbGpPWpGaD
Hydromorphone—PTGS1—Metabolism—GSTM1—head and neck cancer	5.99e-05	0.000595	CbGpPWpGaD
Hydromorphone—OPRM1—GPCR downstream signaling—IL2—head and neck cancer	5.85e-05	0.000581	CbGpPWpGaD
Hydromorphone—OPRD1—Signaling by GPCR—MAPK3—head and neck cancer	5.77e-05	0.000573	CbGpPWpGaD
Hydromorphone—PTGS1—Metabolism—GPX1—head and neck cancer	5.74e-05	0.00057	CbGpPWpGaD
Hydromorphone—UGT1A9—Metabolism of lipids and lipoproteins—PIK3CA—head and neck cancer	5.72e-05	0.000569	CbGpPWpGaD
Hydromorphone—PTGS1—Metabolism—CYP1A1—head and neck cancer	5.68e-05	0.000564	CbGpPWpGaD
Hydromorphone—CYP2D6—Metabolism—DPYD—head and neck cancer	5.64e-05	0.00056	CbGpPWpGaD
Hydromorphone—CYP2C9—Metabolism—DPYD—head and neck cancer	5.59e-05	0.000555	CbGpPWpGaD
Hydromorphone—OPRD1—Signaling by GPCR—MAPK1—head and neck cancer	5.49e-05	0.000545	CbGpPWpGaD
Hydromorphone—OPRD1—Signaling by GPCR—EGFR—head and neck cancer	5.49e-05	0.000545	CbGpPWpGaD
Hydromorphone—OPRK1—Signaling Pathways—NOTCH1—head and neck cancer	5.4e-05	0.000536	CbGpPWpGaD
Hydromorphone—CYP2D6—Metabolism—YAP1—head and neck cancer	5.35e-05	0.000532	CbGpPWpGaD
Hydromorphone—OPRM1—Signaling by GPCR—IL2—head and neck cancer	5.32e-05	0.000528	CbGpPWpGaD
Hydromorphone—CYP2C9—Metabolism—YAP1—head and neck cancer	5.31e-05	0.000527	CbGpPWpGaD
Hydromorphone—OPRD1—GPCR downstream signaling—PIK3CA—head and neck cancer	5.24e-05	0.000521	CbGpPWpGaD
Hydromorphone—OPRK1—Signaling by GPCR—MAPK3—head and neck cancer	5.06e-05	0.000502	CbGpPWpGaD
Hydromorphone—OPRK1—Signaling by GPCR—MAPK1—head and neck cancer	4.81e-05	0.000478	CbGpPWpGaD
Hydromorphone—OPRK1—Signaling by GPCR—EGFR—head and neck cancer	4.81e-05	0.000478	CbGpPWpGaD
Hydromorphone—OPRD1—Signaling by GPCR—PIK3CA—head and neck cancer	4.76e-05	0.000473	CbGpPWpGaD
Hydromorphone—PTGS1—Metabolism of lipids and lipoproteins—PIK3CA—head and neck cancer	4.67e-05	0.000464	CbGpPWpGaD
Hydromorphone—OPRK1—GPCR downstream signaling—PIK3CA—head and neck cancer	4.6e-05	0.000457	CbGpPWpGaD
Hydromorphone—OPRM1—Signaling Pathways—NOTCH1—head and neck cancer	4.56e-05	0.000453	CbGpPWpGaD
Hydromorphone—OPRD1—Signaling by GPCR—HRAS—head and neck cancer	4.4e-05	0.000438	CbGpPWpGaD
Hydromorphone—OPRD1—GPCR downstream signaling—AKT1—head and neck cancer	4.28e-05	0.000425	CbGpPWpGaD
Hydromorphone—OPRM1—Signaling by GPCR—MAPK3—head and neck cancer	4.27e-05	0.000424	CbGpPWpGaD
Hydromorphone—OPRD1—Signaling Pathways—IL2—head and neck cancer	4.24e-05	0.000421	CbGpPWpGaD
Hydromorphone—CYP3A4—Metabolism—NAT2—head and neck cancer	4.21e-05	0.000418	CbGpPWpGaD
Hydromorphone—OPRK1—Signaling by GPCR—PIK3CA—head and neck cancer	4.17e-05	0.000415	CbGpPWpGaD
Hydromorphone—UGT1A9—Metabolism—PTGS2—head and neck cancer	4.14e-05	0.000412	CbGpPWpGaD
Hydromorphone—OPRD1—Signaling Pathways—CCND1—head and neck cancer	4.13e-05	0.00041	CbGpPWpGaD
Hydromorphone—OPRM1—Signaling by GPCR—MAPK1—head and neck cancer	4.07e-05	0.000404	CbGpPWpGaD
Hydromorphone—OPRM1—Signaling by GPCR—EGFR—head and neck cancer	4.07e-05	0.000404	CbGpPWpGaD
Hydromorphone—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—head and neck cancer	3.99e-05	0.000396	CbGpPWpGaD
Hydromorphone—OPRD1—Signaling Pathways—PTEN—head and neck cancer	3.99e-05	0.000396	CbGpPWpGaD
Hydromorphone—OPRD1—Signaling by GPCR—AKT1—head and neck cancer	3.89e-05	0.000386	CbGpPWpGaD
Hydromorphone—OPRM1—GPCR downstream signaling—PIK3CA—head and neck cancer	3.89e-05	0.000386	CbGpPWpGaD
Hydromorphone—OPRK1—Signaling by GPCR—HRAS—head and neck cancer	3.86e-05	0.000384	CbGpPWpGaD
Hydromorphone—OPRK1—GPCR downstream signaling—AKT1—head and neck cancer	3.76e-05	0.000373	CbGpPWpGaD
Hydromorphone—OPRK1—Signaling Pathways—IL2—head and neck cancer	3.72e-05	0.000369	CbGpPWpGaD
Hydromorphone—CYP3A4—Metabolism—DPYD—head and neck cancer	3.69e-05	0.000366	CbGpPWpGaD
Hydromorphone—OPRK1—Signaling Pathways—CCND1—head and neck cancer	3.62e-05	0.00036	CbGpPWpGaD
Hydromorphone—UGT1A9—Metabolism—PTEN—head and neck cancer	3.61e-05	0.000359	CbGpPWpGaD
Hydromorphone—OPRD1—Signaling Pathways—VEGFA—head and neck cancer	3.6e-05	0.000358	CbGpPWpGaD
Hydromorphone—OPRD1—Signaling Pathways—STAT3—head and neck cancer	3.57e-05	0.000354	CbGpPWpGaD
Hydromorphone—OPRM1—Signaling by GPCR—PIK3CA—head and neck cancer	3.53e-05	0.00035	CbGpPWpGaD
Hydromorphone—CYP3A4—Metabolism—YAP1—head and neck cancer	3.5e-05	0.000348	CbGpPWpGaD
Hydromorphone—OPRK1—Signaling Pathways—PTEN—head and neck cancer	3.5e-05	0.000347	CbGpPWpGaD
Hydromorphone—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—head and neck cancer	3.48e-05	0.000345	CbGpPWpGaD
Hydromorphone—OPRK1—Signaling by GPCR—AKT1—head and neck cancer	3.41e-05	0.000339	CbGpPWpGaD
Hydromorphone—OPRD1—Signaling Pathways—MAPK3—head and neck cancer	3.41e-05	0.000338	CbGpPWpGaD
Hydromorphone—PTGS1—Metabolism—PTGS2—head and neck cancer	3.38e-05	0.000336	CbGpPWpGaD
Hydromorphone—OPRM1—Signaling by GPCR—HRAS—head and neck cancer	3.26e-05	0.000324	CbGpPWpGaD
Hydromorphone—OPRD1—Signaling Pathways—MAPK1—head and neck cancer	3.24e-05	0.000322	CbGpPWpGaD
Hydromorphone—OPRD1—Signaling Pathways—EGFR—head and neck cancer	3.24e-05	0.000322	CbGpPWpGaD
Hydromorphone—CYP2D6—Metabolism—TYMS—head and neck cancer	3.21e-05	0.000319	CbGpPWpGaD
Hydromorphone—CYP2C9—Metabolism—TYMS—head and neck cancer	3.19e-05	0.000317	CbGpPWpGaD
Hydromorphone—CYP2D6—Metabolism—GSTM1—head and neck cancer	3.18e-05	0.000316	CbGpPWpGaD
Hydromorphone—OPRM1—GPCR downstream signaling—AKT1—head and neck cancer	3.17e-05	0.000315	CbGpPWpGaD
Hydromorphone—OPRK1—Signaling Pathways—VEGFA—head and neck cancer	3.16e-05	0.000314	CbGpPWpGaD
Hydromorphone—CYP2C9—Metabolism—GSTM1—head and neck cancer	3.15e-05	0.000313	CbGpPWpGaD
Hydromorphone—OPRM1—Signaling Pathways—IL2—head and neck cancer	3.14e-05	0.000312	CbGpPWpGaD
Hydromorphone—OPRK1—Signaling Pathways—STAT3—head and neck cancer	3.13e-05	0.000311	CbGpPWpGaD
Hydromorphone—OPRM1—Signaling Pathways—CCND1—head and neck cancer	3.06e-05	0.000304	CbGpPWpGaD
Hydromorphone—CYP2D6—Metabolism—GPX1—head and neck cancer	3.04e-05	0.000302	CbGpPWpGaD
Hydromorphone—CYP2C9—Metabolism—GPX1—head and neck cancer	3.02e-05	0.0003	CbGpPWpGaD
Hydromorphone—CYP2D6—Metabolism—CYP1A1—head and neck cancer	3.01e-05	0.000299	CbGpPWpGaD
Hydromorphone—OPRK1—Signaling Pathways—MAPK3—head and neck cancer	2.99e-05	0.000297	CbGpPWpGaD
Hydromorphone—CYP2C9—Metabolism—CYP1A1—head and neck cancer	2.99e-05	0.000297	CbGpPWpGaD
Hydromorphone—OPRM1—Signaling Pathways—PTEN—head and neck cancer	2.95e-05	0.000293	CbGpPWpGaD
Hydromorphone—PTGS1—Metabolism—PTEN—head and neck cancer	2.95e-05	0.000293	CbGpPWpGaD
Hydromorphone—OPRM1—Signaling by GPCR—AKT1—head and neck cancer	2.88e-05	0.000286	CbGpPWpGaD
Hydromorphone—OPRK1—Signaling Pathways—MAPK1—head and neck cancer	2.84e-05	0.000282	CbGpPWpGaD
Hydromorphone—OPRK1—Signaling Pathways—EGFR—head and neck cancer	2.84e-05	0.000282	CbGpPWpGaD
Hydromorphone—OPRD1—Signaling Pathways—PIK3CA—head and neck cancer	2.81e-05	0.000279	CbGpPWpGaD
Hydromorphone—OPRD1—Signaling Pathways—TP53—head and neck cancer	2.72e-05	0.00027	CbGpPWpGaD
Hydromorphone—OPRM1—Signaling Pathways—VEGFA—head and neck cancer	2.67e-05	0.000265	CbGpPWpGaD
Hydromorphone—OPRM1—Signaling Pathways—STAT3—head and neck cancer	2.64e-05	0.000262	CbGpPWpGaD
Hydromorphone—OPRD1—Signaling Pathways—HRAS—head and neck cancer	2.6e-05	0.000258	CbGpPWpGaD
Hydromorphone—UGT1A9—Metabolism—PIK3CA—head and neck cancer	2.55e-05	0.000253	CbGpPWpGaD
Hydromorphone—OPRM1—Signaling Pathways—MAPK3—head and neck cancer	2.52e-05	0.000251	CbGpPWpGaD
Hydromorphone—OPRK1—Signaling Pathways—PIK3CA—head and neck cancer	2.47e-05	0.000245	CbGpPWpGaD
Hydromorphone—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—head and neck cancer	2.45e-05	0.000244	CbGpPWpGaD
Hydromorphone—OPRM1—Signaling Pathways—MAPK1—head and neck cancer	2.4e-05	0.000239	CbGpPWpGaD
Hydromorphone—OPRM1—Signaling Pathways—EGFR—head and neck cancer	2.4e-05	0.000239	CbGpPWpGaD
Hydromorphone—OPRK1—Signaling Pathways—TP53—head and neck cancer	2.39e-05	0.000237	CbGpPWpGaD
Hydromorphone—OPRD1—Signaling Pathways—AKT1—head and neck cancer	2.3e-05	0.000228	CbGpPWpGaD
Hydromorphone—OPRK1—Signaling Pathways—HRAS—head and neck cancer	2.28e-05	0.000227	CbGpPWpGaD
Hydromorphone—CYP3A4—Metabolism—TYMS—head and neck cancer	2.1e-05	0.000209	CbGpPWpGaD
Hydromorphone—OPRM1—Signaling Pathways—PIK3CA—head and neck cancer	2.08e-05	0.000207	CbGpPWpGaD
Hydromorphone—UGT1A9—Metabolism—AKT1—head and neck cancer	2.08e-05	0.000207	CbGpPWpGaD
Hydromorphone—PTGS1—Metabolism—PIK3CA—head and neck cancer	2.08e-05	0.000206	CbGpPWpGaD
Hydromorphone—CYP3A4—Metabolism—GSTM1—head and neck cancer	2.08e-05	0.000206	CbGpPWpGaD
Hydromorphone—OPRM1—Signaling Pathways—TP53—head and neck cancer	2.02e-05	0.0002	CbGpPWpGaD
Hydromorphone—OPRK1—Signaling Pathways—AKT1—head and neck cancer	2.01e-05	0.0002	CbGpPWpGaD
Hydromorphone—CYP3A4—Metabolism—GPX1—head and neck cancer	1.99e-05	0.000198	CbGpPWpGaD
Hydromorphone—CYP3A4—Metabolism—CYP1A1—head and neck cancer	1.97e-05	0.000196	CbGpPWpGaD
Hydromorphone—OPRM1—Signaling Pathways—HRAS—head and neck cancer	1.93e-05	0.000192	CbGpPWpGaD
Hydromorphone—CYP2D6—Metabolism—PTGS2—head and neck cancer	1.79e-05	0.000178	CbGpPWpGaD
Hydromorphone—CYP2C9—Metabolism—PTGS2—head and neck cancer	1.78e-05	0.000176	CbGpPWpGaD
Hydromorphone—OPRM1—Signaling Pathways—AKT1—head and neck cancer	1.7e-05	0.000169	CbGpPWpGaD
Hydromorphone—PTGS1—Metabolism—AKT1—head and neck cancer	1.7e-05	0.000169	CbGpPWpGaD
Hydromorphone—CYP2D6—Metabolism—PTEN—head and neck cancer	1.56e-05	0.000155	CbGpPWpGaD
Hydromorphone—CYP2C9—Metabolism—PTEN—head and neck cancer	1.55e-05	0.000154	CbGpPWpGaD
Hydromorphone—CYP3A4—Metabolism—PTGS2—head and neck cancer	1.17e-05	0.000116	CbGpPWpGaD
Hydromorphone—CYP2D6—Metabolism—PIK3CA—head and neck cancer	1.1e-05	0.000109	CbGpPWpGaD
Hydromorphone—CYP2C9—Metabolism—PIK3CA—head and neck cancer	1.09e-05	0.000109	CbGpPWpGaD
Hydromorphone—CYP3A4—Metabolism—PTEN—head and neck cancer	1.02e-05	0.000101	CbGpPWpGaD
Hydromorphone—CYP2D6—Metabolism—AKT1—head and neck cancer	9e-06	8.94e-05	CbGpPWpGaD
Hydromorphone—CYP2C9—Metabolism—AKT1—head and neck cancer	8.92e-06	8.86e-05	CbGpPWpGaD
Hydromorphone—CYP3A4—Metabolism—PIK3CA—head and neck cancer	7.2e-06	7.16e-05	CbGpPWpGaD
Hydromorphone—CYP3A4—Metabolism—AKT1—head and neck cancer	5.89e-06	5.85e-05	CbGpPWpGaD
